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Abstract 
 
Purpose. Toxoplasmosis is a zoonosis, occurred by an etiological agent 
Toxoplasma gondii, and one of the most important infectious diseases in 
immunocompromised patients. But, in Japan, there is little information of 
prevalence of Toxoplasma infection in wild animals as an intermediate host. 
Thus, development of a novel, highly sensitive detection method of 
Toxoplasma has dual significance in an epidemiological research and a 
clinical application. The aim of the present study is to uncover prevalence of 
Toxoplasma infection in a wild animal in Japan and to investigate a novel 
PCR target for the diagnosis of toxoplasmosis. 
Materials and methods. We collected 107 specimens of wild raccoon brains 
in Hokkaido of Japan, and extracted DNA from these specimens. To 
investigate prevalence of Toxoplasma infection, a nested-PCR targeting a B1 
gene that is specific for T. gondii was performed. Consequently, to improve 
PCR diagnosis method, we focused on the cytochrome c oxidase subunit I 
gene (cox1) as a PCR target since copy number of this gene is considered to 
be high. So, we estimated copy numbers per haploid nuclear genome and 
PCR sensitivities of several candidate genes (cox1, B1, 18S rRNA genes and 
the AF146527 fragment) for PCR diagnosis of toxoplasmosis. Finally, the 
cox1-primer was applied to the PCR diagnosis using clinical samples 
obtained from hospitals in Japan. 
Results. A nested-PCR using a DNA sample set of 107 raccoon brains was 
repeated three times at the same condition. In a result, the prevalence of 
Toxoplasma infection of raccoons in Hokkaido was relatively high (36%). 
The copy number of cox1 gene was estimated using DNAs extracted from 
different Toxoplasma genotypes, I and II. Results showed these copy 
numbers were 81.4 and 175.9, respectively. The cox1-PCR has the highest 
sensitivity among PCRs examined in this study. In the cox1-PCR, 
Toxoplasma-specific DNA was detected from five clinical samples in 24 
patients and 6 volunteers. This result suggested that the cox1-PCR system 
would be more sensitive than the other PCR systems using B1, 18S rRNA 
genes and the AF146527 fragment. 
Conclusion. Prevalence of Toxoplasma infection of wild raccoons in 
Hokkaido of Japan was 36.4%. The mitochondrial gene cox1 would be a 
useful target for the PCR diagnosis of toxoplasmosis. 
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Chapter 1. Background 
 
1.1. Toxoplasma 
Toxopalsma gondii is an obligate intracellular parasite, which 
belongs to the phylum Apicomplexa. Cats and their relatives as definitive 
hosts shed Toxoplasma oocysts in feces, and intermediate hosts in nature 
become infected after ingesting soil, water or plants contaminated with its 
oocysts. T. gondii evade host immune systems by forming dormant cysts. 
These cysts would remain for the life of definitive and intermediate hosts 
as an opportunistic pathogen (Yano et al., Book, Toxoplasmosis in Japan, 
2007). This protozoan parasite not only can infect warm blooded 
vertebrates including human, but also exists in cold blooded animals 
(Nasiri et al., 2016). 
Humans get Toxoplasma infection via the following three main ways: 
first, oral ingestion of water or food contaminated with Toxoplasma oocysts 
shed in the feces of definitive hosts; second, the parasite is transmitted by 
consumption of undercooked or raw meat with tissue cysts; third, 
transmission tachyzoites from mother to the fetus (Fig. 1). Toxoplasmosis 
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is a zoonotic infection and, therefore, this disease is very important in both 
clinical and veterinary fields (Hill et al., 2005). It has been predicted that 
more than one-third of the human population may be infected with 
toxoplasmosis in the world (Tenter et al., 2000; Mercier et al., 2011). 
 
1.2. Toxoplasma infection in human 
Toxoplasma has several distinct phenotypes and symptoms occurred 
by its infection, depending on Toxoplasma genotypes. Since toxoplasmosis 
is an opportunistic infectious disease, most healthy people infected with 
toxoplasmosis have no signs or symptoms and may not be aware that they 
are infected. However, some people show developed signs and severe 
clinical symptoms, including swollen lymph nodes, fever, body aches and 
fatigue (Yano et al., Book, Toxoplasmosis in Japan, 2007). For instance, in 
a few cases, an infection with toxoplasmosis cause ocular toxoplasmosis 
(Khan et al., 2006), toxoplasmic encephalitis (Miyagi et al., 2015) in 
immunocompromised patients [i.e., HIV-infected patients (Colombo et al., 
2005) and transplant patients (Derouim and Pelloux, 2008)].  
In addition, congenital toxoplasmosis is a specific form of 
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toxoplasmosis (Sterkers et al., 2012). The primary infection of pregnant 
women with this parasite occasionally leads to spontaneous abortion and 
stillbirth, and may result in neonates developing disease, such as epilepsy, 
retardation, blindness and other neurological disorders in their fetuses 
(Hohlfeld et al., 1994; Remington et al., 1976). 
 
1.3. Toxoplasma infection in wild animals 
Toxoplasmosis is a zoonotic disease. It affects the health and growth 
of poultry and livestock (i.e. pigs, sheep, chicken), and wild animals (wild 
boars, raccoons, snakes, rodents, and so on) as well. It even has an impact 
on social and economic development. Except felids, most animals as 
intermediate hosts get infected by ingesting oocysts or parasitized tissues. 
Similar to situation in humans, although Toxoplasma has capability of 
infecting most wild animals, sensitivity and rates of infection are quite 
different among different species and genotypes. Moreover, rates of 
infection may vary widely in populations of the same species, due to 
differences in location, diet and other factors. Currently, researchers of 
many countries are conducting statistical studies on these wild animals 
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infected with Toxoplasma and analyzing genotypes of T. gondii. 
 
1.4. Diagnosis of toxoplasmosis 
At present, toxoplasmosis is mainly diagnosed by using two 
methods: a serological test and molecular detection. The serological test 
which measures immunoglobulin G (IgG) is used to determine whether a 
person has been infected or not. For a pregnant woman, estimating the 
timing of the infection is particularly important. To determine this infection 
timing, the test which measures immunoglobulin M (IgM) is also used 
along with other tests such as an avidity test. This test is performed as a 
conventional method for laboratory diagnosis (James et al., 1996). 
However, it has some limitations. For example, in immunocompromised 
patients, the titers of specific anti-Toxoplasma IgG or IgM antibodies may 
fail to rise (Porter and Sande, 1992). 
The molecular detection method, which is based on PCR, focuses on 
the detection of T. gondii DNA, making it sensitive, definitive, and 
applicable to all clinical samples (Joss et al., 1993; Bell and Ranford-
Cartwright, 2002; Contini et al., 2005). In general, the copy number of a 
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target region of PCR is very important for increasing the sensitivity of 
DNA detection. However, some published PCRs targeting genes or 
fragments using clinical samples have been reported to yield unstable 
results (Wahab et al., 2010). 
 
1.5. Toxoplasma genotypes  
T. gondii has multiple subpopulation structures in different ethnic 
groups and different geographical regions in global. There are three 
primary genotypes I, II and III, which has been isolated in Northern 
America and Europe (Darde et al., 1992; Howe and Sibley, 1995). These 
three genotypes have difference virulence phenotypes. The type I strain can 
be 100% lethal in mice. In contrast, type II strain (LD50>103 parasites) and 
type III strain (LD50>105 parasites) are less virulent than type I (Sibley and 
Boothroyd, 1992). In humans, major cases of toxoplasmosis were 
associated with strains belonging to type II parasites (Howe and Sibley, 
1995). The immunocompromised patients may have severe clinical 
symptoms when infected with T.gondii. Type III not only predominates in 
humans in Europe, but also more frequently appears in animals than types I 
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and II. Although they have differences in the genome sequence, the 
differences among them is very small (less than 1%) (Sibley et al., 1992). 
Until now, there have been a lot of reports studying on T. gondii genotypes, 
which were used to develop molecular markers among difference hosts and 
in various geographical locations in many countries (Su et al., 2012; 
Lorenzi et al., 2016).  
Except the three typical genotypes, other atypical genotypes were 
also discovered. In South America, high diversity genotypes were found 
(Shwab et al., 2014). In Africa, one sample as Africa 1 genotype (also call 
haplogroup 6, HG6) was identified by microsatellite markers (Can et al., 
2014). In Asia, increasing number of studies have been conducted on 
Toxoplasma genotypes in many countries. A total number of 414 samples 
were genotyped using at least 5 different markers by Chaichan et al. (2017). 
Many data were collected from countries in Western Asia. [For example, 
twenty-four samples of street dogs were collected from Sri Lanka, and 
ToxoDB#2 (type III), ToxoDB#9, Toxo#20, and other various genotypes 
were found (Dubey et al. 2007a. In South India, 16 different genotypes 
were identified from postmortem in 25 AIDS patients (Vijaykumar et al., 
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2016). Type II and Type III genotypes were derived from ducks, stray cats, 
sheep, free-range chickens and humans in Iran (Zia-Ali et al., 2007). In 
Turkey, Type II and III, and HG6 were identified in 22 samples from stray 
cats (Can et al., 2014). In addition, other two strains Ankara and Ege-1 
were found. These strains killed mice in 4-5 days (Doskaya et al., 2013). 
ToxoDB#3 genotype was discovered from sand cats in Qatar (Dubey et al., 
2010). In United Arab Emirates, 3 sand cat samples were collected and 
tested, 2 of them had genotype ToxoDB#20 and 1 sample had an 
incomplete atypical genotype (Dubey et al., 2010). 
In the tropical Southeast Asian countries, 43 toxoplasma strains were 
completely characterized, and most of them were Type I strains or atypical 
genotypes with majority of Type I alleles. In South Korea, the KI-1 (Type I) 
was isolated from a patient with ocular lesions (Quan et al., 2008). 
Genotype Toxo#89 was isolated from free-range chicken in Indonesia 
(Dubey et al., 2008), and this genotype Toxo#89 was found only in 
Indonesia. In Malaysia, incomplete typing, 2 with Type II alleles and 2 with 
Type I alleles were isolated from 19 samples (ducks and boars) 
(Puvanesuaran et al., 2012; Puvanesuaran et al., 2013) using 7 PCR-RFLP 
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markers. In Myanmar, 19 DNA extracts of bats were collected.Four extracts 
belonged to genotype ToxoDB#10 and the 15 remaining samples gave 14 
different atypical genotypes with a majority of Type I alleles, revealing a 
high diversity among these wild animals (Sun et al., 2013); A total number 
of 8 strains isolated from unwanted dogs were characterized in Vietnam. 
And they found 4 ToxoDB#9 and 4 Toxo#DB18 genotypes (Dubey et al., 
2007b). The Toxo#DB18 genotype was also described in the nearby 
province of Guangzhong in South China (Dubey et al., 2007c).] China also 
have performed a lot of studies on Toxoplasma genotypes. Currently, a total 
of 278 samples (154 DNA extracts and 124 isolates) from 33 human and 
245 animal strains were characterized. Thirteen ToxoDB genotypes and 5 
atypical genotypes were identified in China. The most common genotype 
was ToxoDB#9 (Chinese1), with 65.5% of total samples. ToxoDB#10 
(Type I) is second most common genotype with a proportion of 18.3%. The 
clonal types II (ToxoDB#1 and #3) and III (ToxoDB#2), and the genotype 
#205 were less frequently (Chaichan et al., 2017).  
Japan is an island country that lies off the eastern coast of the Asian 
continent (Fig. 2). The mild and humid of temperate climate is good for the 
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growth of plants and animals in most of the Japanese archipelago. Animal 
biodiversity is rich, and local people have their own unique habits of eating 
raw meat (i.e. fish, chicken, horse and so on) that potentially increase the 
risk of T. gondii infection. This may have particular consequences if 
infection occurs in pregnant women and immunocompromised individuals 
(Afonso et al., 2012). However, the number of studies on Toxoplasma 
genotypes in humans and animals is relatively few.  
Zakimi (2006) conducted genotyping and analyzed the virulence of 
T. gondii in domestic pigs, but only 5 genetic markers were used in the 
experiment. Moreover, one of the five markers were the dense granule 
antigens (GRA6) marker (Sibley et al., 1992) and the GRA6 sequencing 
showed a higher polymorphism (Zakimi et al., 2006; Kyan et al., 2012). 
The small number of genetic maker types for PCR-RFLP and the 
polymorphism of the GRA6 would reduce the reliability and accuracy of T. 
gondii genotyping in this analysis (Zakimi et al., 2006). 
 
1.6. Research objective 
So far, there is not enough information on whether wild animals are 
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infected with T. gondii in Japan. In addition, the genotypes and their 
associated virulence of T. gondii isolated from animals and humans are 
largely unclear. Therefore, understanding the epidemiology and genetic 
characteristics of T. gondii is important and urgent. In this situation, I 
performed a study in this doctoral thesis. The main objectives of the present 
study are to investigate prevalence of Toxoplasma infection in a wild 
animal in Japan, and to develop a method for toxoplasmosis diagnosis by 
designing a novel Toxoplasma-specific PCR target. 
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Chapter 2. Detection of Toxoplasma DNA in wild animals - Raccoons 
 
2.1. Introduction 
The raccoon (Procyon lotor) is a medium-sized mammal native to 
North America (Poglayen-Neuwall, 1990). As a result of escapes and 
deliberate introductions in the mid-20th century, raccoons are now also 
distributed across much of mainland Europe, Caucasus, and Japan. The 
raccoons may be one of the world's most omnivorous animals. Its diet 
consists not only nuts but also small animals, such as mouse, bird and fish.  
 In the early 1970s, with the increase of the Japanese economy, many kinds 
of small and medium-sized animals have been imported into Japan as pets 
(Ikeda et al., 2004). Gradually over 30 species of animals have thus far 
naturalized in Japan, including raccoons (The Committee on Mammal 
Conservation and Management, 1999). However, not long after many 
raccoons were either abandoned or discarded into the wild, and in the 
meantime, the invasive alien raccoons can easily establish its vivo-sphere 
in Japan, because they have no natural enemies in Japan such as the bobcat 
or the coyote. Therefore, there is a serious problem of subsequent 
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expansion of the invasive alien raccoon population (Sato et al., 2011). The 
increased raccoons have caused heavy problems to crops or native 
ecosystems,  and the close habitation to human residences and 
domesticated animals raises the potential risks of releasing non-indigenous 
pathogens such as rabies (Real et al., 2005), toxoplasmosis (Hancock et al., 
2005) and babesiosis (Jinnai et al., 2009). 
So far, detection of seroprevalence of T. gondii have been used in test 
for animals, mainly including domestic animals and a small number of wild 
animals (Fujii et al., 2007; Matsuo et al., 2014), as well as in antenatal test 
for early pregnancies (Yamada et al., 2011; Sakikawa et al., 2012). 
However, so far, there are no report on genotyping of T. gondii. Moreover, 
whether there is a link between genotypes of T. gondii in infected wild 
animals and in infected humans in Japan remains unclear. 
Hence, we selected an omnivorous wild animal - raccoons for 
epidemiology of T. gondii in Japan. The objective of the present study is to 
investigate the T. gondii prevalence to provide base-line information for 
controlling Toxoplasma infection in raccoons of Japan.  
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2.2. Materials and methods 
2.2.1. Research area 
Hokkaido is located at the north end of Japan, near Russia. It is the 
second largest main island and the largest prefecture of Japan in 
geographical (Fig. 2). The Tsugaru Strait separates Hokkaido from Honshu, 
which made Hokkaido an independent island. The southwest of Hokkaido 
is the oceanic climate and warm and humid climate, the other areas have 
subarctic humid climate. The unique climate and geographical location 
make Hokkaido have fertile soil and abundant animals and plants. 
 
2.2.2. Brain specimens of raccoons 
In Hokkaido, over-reproduced wild animals have affected normally 
growth of economic crops and the development of the local ecological 
environment. Extreme measure for these wild animals (such as, boars, 
rabbits and raccoons, and so on) is taken in this area from time to time. In 
this study, 107 brain specimens of wild raccoons, which were provided 
from the Obihiro University of Agriculture and Veterinary Medicine in 
Hokkaido, were collected from field environment at an eastern area of 
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Hokkaido, during Jan. 2017 to Oct. 2017. These 107 raccoon samples 
include 47 females and 60 males. Brain specimens were collected in 1.5 ml 
tubes and stored at -30°C until used.  
 
2.2.3. DNA Extraction 
    The DNA was extracted from brain tissue samples using the 
NucleoSpin® DNA RapidLyse kit (MACHEREY-NAGEL GmbH Co. KG 
Duren, Germany) technique, and the DNA was stored at -30°C until 
used.Each sample was measured 30 – 40 mg and put into a 2 ml tube. Add 
150 µl lysis buffer (Buffer RLY), pipetting and add 10 µl Liquid Proteinase 
K. The mixture sample was Incubated in 56 °C water bath 1 hour and 
vortex until the sample appears visually lysed. Centrifuge the tube at 
11,000 x g for approx. and short spin in order to clean the lid.  
Next, add 400 µl binding buffer (Buffer RLB) and vortex. Apply 
about 640 µl mixture onto the NucleoSpin® DNA RapidLyse Column 
placed into a 2 ml Collection Tube, and centrifuge for 1 min at 11,000 x g. 
Discard Collection Tube with flow through, put column into a fresh 2 ml 
Collection tube. The centrifuged sample was washed using 500 µl wash 
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buffer (Buffer RLW) that 250 µl original RLW-buffer with 100 µl 100% 
ethanol and centrifuge for 1 min at 11,000 x g. Discard flow-through and 
place column back into the Collection Tube. The same step was repeated 
centrifuge for 1 min at 11,000 x g. Place the NucleoSpin® DNA RapidLyse 
Column into a 1.5 ml nuclease-free tube and add 100 µl Elution buffer 
(Buffer RLE) onto the column, and centrifuge for 1 min at 11,000 x g. The 
extracted DNA concentration was measured and stock at -30 °C until used. 
This protocol was modified and executed according to MACHEREY-
NAGEL company.  
 
2.2.4. Detection of Toxoplasma DNA using nested- PCR targeting a B1 
gene 
The B1 gene nested-PCR was performed as base to survey the 107 
tissue samples using PCR. The Tks Gflex DNA Polymerase (TaKaRa, 
Japan) was used to amplify a targeted DNA fragment. In 1st PCR, the 20 µl 
PCR reaction include 2x Gflex PCR buffer, Tks Gflex DNA Polymerase 
(1.25 U/µl) and 0.3 µM each of external forward (5’-
TGTTCTGTCCTATCGCAACG-3’) and reverse primers (5’-
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ACGGATGCAGTTCCTTTCTG-3’). PCR condition was performed 94 °C 
for 1 min, followed by 35 cycles of 98 °C for 10 sec, 55 °C for 15 sec, 
68 °C for 40 sec. The 1st PCR amplified products was diluted five times by 
MilliQ water. The nested PCR reaction was performed 20 µl, containing 2x 
Gflex PCR buffer, 1.25 U/µl Tks Gflex DNA Polymerase, 0.3 µM each of 
B1 gene of internal forward (5’-TCTTCCCAGACGTGGATTTC-3’) and 
reverse primers (5’-CTCGACAATACGCTGCTTGA-3’), and 2 µl of 
diluted 1st PCR products. The reaction mixture is treated at 94 °C for 1 min, 
followed by 35 cycles of 98 °C for 10 sec, 55 °C for 15 sec, 68 °C for 40 
sec. The primers sequences expected size of PCR products, and PCR 
conditions for amplification of the B1 gene are shown in Table 1. 
 
2.3. Results  
In this study, 107 DNA samples of raccoon brain tissues were 
collected, and preformed nested PCR using primers targeting the B1 gene. 
The nested PCR was performed three times at the same PCR condition. The 
positive control yielded an expected signal of 531 bp in size. In a first trial, 
the nested PCR results showed that Toxoplasma DNA was found in 13% of 
brain tissue sample of raccoons (14 of 107). In the second nested PCR, 
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12% (13/107) samples showed the specific band. In the third nested PCR, 
20% (22/107) samples of Toxoplasma DNA was detected (Fig. 3). The 
results of the three times nested PCR tests were shownin Table 2. Totally, 
Toxoplasma DNA was detected in 39 samples out of 107 brains of wild 
raccoons.  
 
2.4. Discussion 
In the early 70s, with the import of exotic animal and plant species, 
the natural environment had many problems in Japan. The excessive 
wildlife reproduction affects the growth of local native flora and fauna, and 
even human habitats and growth of economic crops. For example, wild 
raccoon, it not only plunders many of crops but also can spread some 
anthropozoonosis, such as rabies, toxoplasmosis and babesiosis (Real et al., 
2005; Hancock et al., 2005; Jinnai et al., 2009). 
In this study, we utilized traditional nested-PCR with B1 gene primer 
sets to investigate the prevalence of T. gondii infection in 107 wild raccoon 
samples from an eastern area of Hokkaido, Japan. Our result showed that 
the infection rate of Toxoplasma was 36% (39/107) in wild raccoon. This 
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prevalence would be higher when compared with the previous report of 
seroprevalence test of raccoons (7.9%) (Sato et al., 2011), suggesting that 
PCR detection would have higher sensitivity than serological tests. 
Nonetheless, there are some false-positive samples found at nested-PCR 
results. Possible reasons are as fellows. One possible reason is that the wild 
raccoons were infected by other parasites closely related to T. gondii, in 
addition to Toxoplasma. T. gondii, Neospora caninum, Sarcocystis spp. and 
Hammondia hammondi are all apicomplexan protozoan parasites in the 
family of Sarcocystidae (Buxton, 1998). They can cause mortality in many 
species of domestic and wild animals (Dubey et al., 2003). Raccoons are an 
omnivorous animal because it has a wide selection of food, and as a result 
they are susceptible to a variety of parasites. Because these parasites have 
similar genome with T. gondii, when applying PCR with B1 gene primers, 
it is easy to obtain false-positive. To solve this problem, in the future, we 
will select all samples in raccoon samples using PCR target for other 
parasites, such as N. caninum, Sarcocystis spp. and H. hammondi. In 
addition, extremely low concentration of Toxoplasma DNA in raccoon 
brains may also be one of the reasons for unstable results. The weight of 
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brain tissues of raccoon is about 300-400 g. However, we used only 35-40 
mg to extract DNA, and these tissues were taken by random. In raccoons 
that have been infected with Toxoplasma gondii with no clinical symptoms, 
the dormant cysts mainly exist in brain, eyes and muscular tissues in body. 
These cysts content is too low to be detected accurately at once. Therefore, 
the negative results in PCR experiments may due to low content of T. 
gondii rather than no infection, which needs further investigations.  
Furthermore, the B1 gene primer yield unstable results (Wahab et al., 
2010), as it would become low sensitivity in PCR when concentration of 
sample was very low.  
 
2.5. Summary 
In this study, we used 107 raccoon samples from Hokkaido, and the 
DNA was extracted from these samples. All DNA samples were tested 
whether infected with T. gondii by PCR using B1 gene primer set. The 
result showed that thirty-nine of the samples infected with T. gondii, 
reaching 36% of the total samples.  
It is difficult to detect the gene of T. gondii from a small number of 
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tissue samples. The negative results cannot really indicate that the samples 
from raccoons in Hokkaido did not infect with T. gondii by PCR detection. 
In the PCR result, the false-positive results may be due to the B1 gene set is 
unstable when the concentration of the sample is very low.  
Therefore, next, we will design a PCR primer that is more stable and more 
sensitive than B1 and other reported primer sets for the detection of T. 
gondii.  
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Chapter 3. Design a novel PCR target for detection of toxoplasmosis in 
clinical samples 
 
3.1. Introduction 
Toxoplasmosis belong to an opportunistic infectious disease, and it is 
zoonotic and consequently very important in clinical and veterinary fields 
(Hill et al., 2005). In domestic animals such as sheep, goats, and cattle, 
abortion caused by T. gondii infection is a major economic problem in their 
industry (Dubey, 2010). In humans, T. gondii is an important etiological 
agent of an opportunistic infectious disease and consequently causes severe 
clinical symptoms in immunocompromised patients [i.e., transplant patients 
(Derouin and Pelloux, 2008) and HIV-infected patients (Colombo et al., 
2005)], such as ocular toxoplasmosis (Khan et al., 2006), toxoplasmic 
encephalitis (Miyagi et al., 2015), and pulmonary toxoplasmosis (Sumi et 
al., 2016). In addition, the primary infection of pregnant women with this 
parasite occasionally leads to serious consequences (e.g., spontaneous 
abortion and stillbirth), and may result in neonates developing debilitating 
disease manifestations including epilepsy, encephalitis, retardation, 
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blindness, and other neurological disorders (Hohlfeld et al., 1994; Roizen et 
al., 1995). Since the diseases that are caused by Toxoplasma infection are 
progressive, the early diagnosis of toxoplasmosis is essential. 
At present, toxoplasmosis is mainly diagnosed using two methods: a 
serological test and molecular detection. The serological test detects 
specific anti-Toxoplasma immunoglobulin (IgG and IgM) and is performed 
as a conventional method for laboratory diagnosis (James et al., 1996); 
however, it has some limitations [e.g., in immunocompromised patients, the 
titers of specific anti-Toxoplasma IgG or IgM antibodies may fail to rise 
(Porter and Sande, 1992)]. The molecular detection method, which is based 
on PCR, focuses on the detection of T. gondii DNA, making it sensitive, 
definitive, and applicable to all clinical samples (Joss et al., 1993; Bell and 
Ranford-Cartwright, 2002; Contini et al., 2005). In general, the copy 
number of a target region of PCR is very important for increasing the 
sensitivity of DNA detection and so high copy number fragments in the 
Toxoplasma genome, such as the B1 gene [35 copies (Burg et al., 1989; 
Pelloux et al., 1996)], 18S rRNA gene [110 copies (Guay et al., 1992)], and 
AF146527 repeat element [200–300 copies (Homan et al., 2000)], have 
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been proposed for the PCR diagnosis of toxoplasmosis. However, PCRs 
targeting these genes and fragment using clinical samples have been 
reported to yield unstable results (Wahab et al., 2010). Therefore, there is 
currently no consensus regarding the most effective method of PCR 
amplification of Toxoplasma DNA, highlighting the need for a novel target 
that increases the PCR detection sensitivity. 
Like other eukaryotes, apicomplexan parasites including T. gondii 
also contain mitochondrial DNA (mtDNA) (Hikosaka et al., 2013), the 
copy number of which per haploid nuclear genome is generally considered 
to be relatively high. In malaria parasites, which are closely related to T. 
gondii, the copy numbers of mtDNA have been estimated at 50 to 150 
(Hikosaka et al., 2013), indicating that T. gondii mtDNA may also have a 
high copy number. Furthermore, large amounts of fragment of the mtDNA-
encoded genes cytochrome c oxidase subunit I (cox1) and cytochrome b 
(cob) have been found in the nuclear genomes of T. gondii (Ossorio et al., 
1991). The complete nucleotide sequences of the cox1 and cob genes of 
this parasite (RH strain) have been reported (Gjerde, 2013) although the 
mitochondrial genome structure of T. gondii has not yet been determined 
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(Hikosaka et al., 2013), and the sequence of cob is more highly divergent 
than that of cox1 in other apicomplexan parasites, such as Plasmodium 
(Hikosaka et al., 2011). Therefore, in this study, we focused on cox1 as a 
target of PCR for the diagnosis of toxoplasmosis. We first designed a PCR 
primer set targeting the mitochondrial gene cox1 and then compared the 
detection sensitivity of the PCR using this primer set with PCRs using 
other previously reported primer sets. We also confirmed the utility of 
cox1-primers for the PCR diagnosis of toxoplasmosis using clinical 
samples. Our findings suggested that the use of PCR targeting cox1 would 
facilitate the diagnosis of toxoplasmosis in clinical laboratories. 
 
3.2. Materials and methods 
3.2.1. Ethical approval 
    All animal experiments in this study were conducted in accordance 
with the guidelines for the use of animals of Chiba University, Japan 
(Permit number: 29-271). Ethical permission for the study of clinical 
samples was obtained from the Institutional Review Board of the Graduate 
School of Medicine at Chiba University (Permit number: 2288), which 
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records and regulates all research activities in the university. 
 
3.2.2. Parasite DNA 
    Parasite DNA were extracted from two strains of T. gondii, Fukaya 
and RH. The Fukaya strain has been routinely passaged through mice in 
our laboratory via oral infection using 8-13 week old male C57BL/6j mice 
purchased from Japan SLC, Inc. (Hamamtsu, Japan). In this study, we 
orally infected mice with three cysts of the Fukaya strain in 500 µl 
phosphate- buffered saline (PBS), PH7.2, using syringe fitted with a 19-
guage round-ended needle. We then had increased the number of parasites 
in mice for three months. To isolate the tissue cysts of T. gondii, brain 
tissue of a parasite-infected mouse was homogenized with a pestle in 10 ml 
PBS and filtered through 100 μm nylon mesh in order to wash out any 
extraneous tissue debris. Subsequently, the number of cysts was evaluated 
with an upright microscope (Olympus BX40: Olympus, Tokyo, Japan) (11 
cysts/100 μl brain tissue solution). The brain homogenate including cysts 
was stored at 4 °C until use. The RH strain of T. gondii had been 
continuously cultured in the human lymphoma cell line ARH (Yano et al., 
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1989). When almost all ARH cells were ruptured due to T. gondii infection, 
released parasites were collected together with some ARH cells infected 
with or without T. gondii and suspended in the freezing medium [60% (v/v) 
RPMI1640 medium, 30% (v/v) fetus bovine serum, 10% (v/v) dimethyl 
sulfoxide]. These cells were stored at −80 °C until use. The total DNAs of 
the Fukaya and RH strains of T. gondii were extracted from the cyst 
solution and parasite-infected cells, respectively, using the DNeasy® Blood 
and Tissue Kit (Qiagen, Hilden, Germany) according to the manufacturer's 
instructions. The extracted total DNAs were then suspended in the Buffer 
AE, included in the kit, and stored at −30 °C until use. 
 
3.2.3. Primer design 
    Primers for the amplification of a cox1 gene fragment were designed 
by aligning the reported nucleotide sequences of Neospora caninum 
(GenBank accession number, JX473252), Hammondia triffittae 
(JX473247), and H. heydorni (JX473250), in addition to T. gondii (RH and 
ME49 strains; JX473253 and KE139165, respectively). N. caninum, H. 
triffitae, and H. heydorni are closely related to the Toxoplasma genus. 
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Primers for real-time PCR targeting the 18S rRNA and SAG1 (P30) genes 
were designed using nucleotide sequences of the RH strain (M97703) and 
the ME49 strain (XM_002368164), respectively. The other primers for 
real-time PCR were obtained based upon the report by Costa and Bretagne 
(Costa and Bretagne, 2012). The nucleotide sequences of these primers are 
listed in Table 4. The primers for the B1 and 18S rRNA genes and the 
AF146527 repeat element for conventional PCR were obtained based upon 
previous reports (Homan et al., 2000; Dupon et al., 1995; Okay et al., 2009) 
(Table 5). 
 
3.2.4. Real-time PCR 
    To investigate the copy numbers per haploid nuclear genome of the 
genes and repeat elements examined in this study, we performed a real-time 
quantitative PCR using the single copy gene SAG1 as a reference. The 
primers that were used in the real-time PCR are listed in Table S1. The 
PCR reaction was performed with a QuantiNova® SYBR® Green PCR Kit 
(Qiagen) according to the manufacturer's instructions, and real-time PCR 
analysis was conducted with an ABI PRISM® 7300 Sequence Detection 
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System (Applied Biosystems, California, USA). Each experiment was 
performed in triplicate using various combinations of the PCR target 
reaction mixtures in the same 96-well plate in a single run. 
 
3.2.5. PCR conditions 
    The annealing temperature was optimized using a gradient PCR 
method with the PCR Thermal Cycler Dice Gradient TP600 (TaKaRa, 
Japan). The T. gondii DNA solution was diluted 103 and 104 times. The 
gradient PCR conditions were as follows: initial denaturation at 95 °C for 
10 min, followed by amplification for 35 cycles at 95 °C for 30 s, 48.0–
66.0 °C (12 groups, depending on the equipment setting) for 30 s, and 
72 °C for 30 s, and final extension at 72 °C for 7 min. The results of this 
PCR (data not shown) showed that the optimal annealing temperature of 
the cox1 primer set was 52 °C. The B1 gene, AF146527 repeat element, 
and 18S rRNA gene were used as other targets to compare the PCR 
detection sensitivities for Toxoplasma DNA. The primer sets, annealing 
temperatures, and extension times used in these PCRs are listed in Table 5. 
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3.2.6. Detection sensitivities of PCRs 
To determine the detection sensitivities of the PCRs, we performed 
five-fold serial dilution (5–57) of the DNA solution using distilled 
deionized water (DDW). The PCRs were performed in 20 μl of reaction 
mixture containing 2 μl of the diluted DNA solution using AmpliTaq® 360 
DNA Polymerase (Applied Biosystems, Life Technologies, Carlsbad, CA, 
USA). The amplification cycle targeting the cox1 gene primer was as 
follow: initial denaturation at 95 °C for 10 min, followed by amplification 
for 35 cycles at 95 °C for 30 s, 52 °C for 30 s, and 72 °C for 30 s, and final 
extension at 72 °C for 7 min. The PCR conditions using the other primers 
are shown in Table 5. Following this, 10 μl of the PCR products was 
analyzed by electrophoresis on 1.5% agarose gels. 
 
3.2.7. PCR using clinical samples 
    We previously performed PCR diagnosis of clinical specimens (blood, 
cerebrospinal fluid, amniotic fluid, etc.) that were obtained from hospitals 
in Japan. Here, we selected 24 cases in which PCR diagnosis of 
toxoplasmosis had been completed using blood samples [10 of which were 
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positive (Case No. 1, 5, 6, 11, 15, 17, 18, 20, 22, and 23) and 14 of which 
were negative]. These blood samples had been collected from February 
2013 to April 2017, and PCR diagnosis was performed using previously 
described method (Grigg and Boothroyd, 2001). Clinical histories of 
patients were summarized in Table 6. In addition to these patient 
specimens, we also used blood samples collected from six asymptomatic 
volunteers. To determine the detection sensitivities of the PCRs, DNA 
solutions extracted from the blood were diluted 5 times and 52 times using 
DDW. The PCR conditions for each primer set were identical to those 
described above in the “Detection sensitivities of PCRs” section except for 
the addition of 4 mg/ml bovine serum albumin (BSA; Sigma, St. Louis, 
MO) (final concentration). BSA has the potential to relieve PCR inhibitors 
such as heme in the blood (Kreader, 1996). Each PCR was repeated twice. 
 
3.3. Results 
3.3.1. Estimation of copy numbers of the cox1 gene, B1 gene, AF146527 
repeat element, and 18S rRNA gene 
   To estimate the copy numbers per haploid nuclear genome of the cox1, 
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B1, and 18S rRNA genes, and the AF146527 repeat element, we performed 
quantitative real-time PCR using DNAs extracted from two distinct strains 
of T.gondii, Fukaya and RH, which belong to Toxoplasma clades genotype 
II and genotype I, respectively (Howe and Sibley, 1995). The single copy 
gene SAG1 was used as a reference. In the Fukaya strain, the copy numbers 
of the cox1 gene, B1 gene, AF146527 element, and 18S rRNA gene were 
estimated to be 175.9, 16.6, 353.6, and 61.5, respectively (Table 4), and the 
estimated copy numbers in the RH strain showed a similar tendency (81.4, 
16.4, 197.7, and 38.0, respectively). These findings suggest that PCR 
targeting the cox1 gene would have high potential for detecting 
Toxoplasma DNA due to the high copy number of this gene. 
 
3.3.2. Sensitivities of PCR diagnoses 
   The PCR targeting cox1 detected Toxoplasma DNA in DNA solutions 
diluted from 5 to 55 times (Fig. 4). By contrast, the other PCRs targeting 
B1, AF146527, and 18S rRNA detected the parasite DNA in DNA solutions 
diluted from 5 to 52 times, 5 to 53 times, and 5 to 54 times, respectively. 
These results demonstrate that cox1-PCR would have the highest sensitivity 
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for detecting Toxoplasma DNA among the PCRs examined. 
 
3.3.3. PCR sensitivities using clinical samples 
   To compare the detection sensitivities of PCRs targeting cox1, B1, 
AF146527, and 18S rRNA, we extracted DNA from blood samples from 24 
patients for whom we had previously completed a PCR diagnosis of 
toxoplasmosis in our laboratory, 10 of whom tested positive and 14 of 
whom tested negative. In addition, we also used six blood samples 
collected from asymptomatic volunteers as a negative control. The PCR 
trials using these clinical samples were performed in duplicate. The results 
of these PCRs are summarized in Table 6, and the results of electrophoresis 
analysis are shown in Fig. 5A (first trial) and 5B (second trial). In the cox1-
PCR, the amplification of Toxoplasma-specific DNA was detected in five 
clinical samples (Case numbers 1, 5, 15, 20, and 22). By contrast, PCRs 
targeting the other genes (B1 and18S rRNA) and the repeat element 
(AF146527) were unable to detect the parasite DNA in some of the five 
positive samples. These results suggest that PCR using cox1 primers would 
be useful in the clinical diagnosis of toxoplasmosis. 
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3.4. Discussion 
In this study, we estimated the utility of the mitochondrial gene cox1 
as a target for the PCR diagnosis of toxoplasmosis. The copy numbers per 
haploid nuclear genome of the cox1 gene in the Fukaya and RH strains of 
T. gondii were predicted to be 175.9 and 81.4, respectively, suggesting that 
PCR targeting this gene would have a sufficient efficiency for the diagnosis 
of toxoplasmosis. A comparison of the detection limit of cox1 and 
previously reported genes (B1 and 18S rRNA) and the AF146527 repeat 
element showed that PCR using cox1 primers amplified Toxoplasma-
specific DNA the most efficiently. Furthermore, an investigation of the 
detection sensitivities of PCRs using DNA extracted from clinical samples 
demonstrated that, unlike the other targets, cox1-PCR could amplify 
parasite DNA in five samples (Table 6). These results indicate that the cox1 
gene would be an excellent target of PCR in the diagnosis of 
toxoplasmosis. We estimated the copy number of each gene examined in 
this study using two strains of T. gondii, Fukaya and RH, which had 
different copy numbers of cox1 (Table 4). DNA of the Fukaya strain 
(genotype II), which is generally detected in humans and has low 
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pathogenicity (Howe and Sibley, 1995), was extracted from cysts in a 
mouse brain. The developmental stage of these parasites in the cyst was 
morphologically considered to be a bradyzoite. By contrast, DNA of the 
RH strain, (genotype I), which has high pathogenicity, was extracted from 
infected culture cells. The stage of this parasite was morphologically 
considered to be a tachyzoite. Since the bradyzoite and tachyzoite stages 
are considered to be inactive and active phases of the parasite life cycle, 
respectively, they are likely to have different levels of metabolism, which 
may affect the copy number of mtDNA that encode genes involving energy 
production, including cox1. The copy numbers of the B1 gene of Fukaya 
and RH were evaluated to be 16.6 and 16.4, respectively, which differs 
from the numbers reported in previous studies (Contini et al., 2005; Costa 
and Bretagne, 2012). Similarly, the copy numbers of the AF146527 repeat 
element examined in this study also differed from previous reports (Homan 
et al., 2000; Costa and Bretagne, 2012). These incongruent findings will 
have been caused by the different methods that were used to evaluate the 
copy numbers between studies. The copy number of the 18S rRNA gene in 
the Toxoplasma nuclear genome has been reported as 110 by Guay's 
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research group (Guay et al., 1992), which is considerably higher than the 
values obtained for Fukaya and RH in the present study (61.5 and 38, 
respectively). It has previously been shown that the copy number of the 
18S rRNA gene in the genus Eimeria, which is closely related to 
Toxoplasma, is 140 (Torres-Machorro et al., 2010) and that their nucleotide 
sequences are divergent (El-Sherry et al., 2013). Thus, we can infer that 
there were also divergent 18S rRNA gene paralogs in the Toxoplasma 
nuclear genome. Therefore, incomplete annealing of the PCR primers to the 
nucleotide sequences of this gene may have generated variable evaluations 
of its copy number. 
Evaluation of the detection sensitivities of PCRs using primers 
targeting the genes and repeat fragment examined here demonstrated that 
cox1-PCR is most effective in amplifying Toxoplasma DNA. Furthermore, 
we found that cox1-PCR was most effective when using clinical samples. 
The nucleotide sequence of cox1 will be highly conserved despite its high 
copy number, since the protein COX1 is essential for energy production in 
the mitochondria. By contrast, it has been reported that the relative 
proportion of different gene structures, such as insertions/deletions, 
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mutations, and the number of repeats, in B1, AF146527, and 18S rRNA 
differs among clinical isolates of T. gondii (Wahab et al., 2010; Costa and 
Bretagne, 2012). Taken together, these findings suggest that the high 
conservation and few variations of cox1 nucleotide sequences among the 
isolates of T. gondii result in increased PCR detection sensitivities. 
 
3.5. Summary 
We demonstrated that the mtDNA-encoded cox1 gene would be a 
useful target for the PCR diagnosis of toxoplasmosis. Since nested PCR 
and real-time PCR can further increase the detection sensitivity of PCR, 
investigation of these methods using the cox1 gene as a target is required in 
the future. 
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Primers Sequences (5'-3') Size (bp) PCR conditions 
First 
round 
     
sense1 5’-TGTTCTGTCCTATCGCAACG-3’ 
580 
94°C for 1 min followed by 35 cycles of 
98°C for 10 sec, 55°C for 15 sec, 68°C for 
40 sec 
anti-
sense1 5’-ACGGATGCAGTTCCTTTCTG-3’ 
Second 
round 
     
sense2 5’-TCTTCCCAGACGTGGATTTC-3’ 
531 
94°C for 1 min, followed by 35 cycles of 
98°C for 10 sec, 55°C for 15 sec, 68°C for 
40 sec anti-sense2 5’-CTCGACAATACGCTGCTTGA-3’ 
Table 1. PCR primers and conditions used in this study 
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1st 2nd 3rd
303 140.0 ー ー/＋ ー
304 40.5 ー ＋ ー
308 361.0 ー ー ー
311 355.0 ＋ ー ＋
312 129.5 ー ー ＋
315 40.0 ー/＋ ー ー
316 89.5 ー/＋ ー ー
317 270.0 ー ー ＋
318 296.0 ー ー ー
319 61.0 ー ＋ ー
320 121.5 ー ＋ ＋
321 84.0 ー ー ＋
328 163.5 ー ー ＋
329 109.0 ＋ ー ー
341 245.5 ー ー ー
348 346.0 ー ー ー
349 100.0 ー/＋ ー ー
350 267.0 ー ー ＋
351 104.0 ＋ ＋ ー
352 144.5 ー ー ー
353 110.0 ー ー ー
354 239.0 ー ー ー
357 177.0 ＋ ー ー
359 336.0 ー ー ー/＋
365 173.0 ー ー ＋
366 234.0 ー ー ー
367 102.5 ー ー ー
368 170.0 ＋ ー ー
369 86.5 ー ー ー
370 189.5 ー ー ＋
371 265.5 ー ー ＋
372 115.0 ー ＋ ー
373 367.5 ー ＋ ー
374 216.0 ー ー ー
375 79.0 ー ー ー/＋
376 92.0 ー ー ー/＋
377 135.5 ー ー ＋
378 328.0 ー ー ー
379 381.5 ー ー ー
380 250.0 ー ＋ ー
381 173.5 ー/＋ ー ー
383 133.5 ー ー ＋
384 156.0 ー ー ＋
385 226.0 ー ー ー
386 188.0 ー ー ー
387 73.0 ー/＋ ー ー
388 139.0 ー ＋ ＋
389 178.0 ー ー ー
390 299.0 ＋ ＋ ー
392 159.0 ー/＋ ー ー
393 100.0 ＋ ー ＋
394 159.0 ー ＋ ー
395 117.0 ー ー ー
Sample No. DNA conc. (ng/µl)
Nested-PCR
1st 2nd 3rd
219 197.5 ＋ ー ー
235 160.5 ー ー ＋
236 171.0 ー ー ー
237 153.0 ー ー ー
238 182.5 ー ー ー
241 66.5 ー ー ー
242 91.5 ー ー ー
243 289.5 ＋ ー ー
244 107.0 ＋ ー ＋
246 144.5 ー ー ー
247 140.0 ー ー ー
249 261.5 ー ー ー
250 115.5 ー ー ー
251 154.5 ー ー ＋
252 227.5 ー ー ー
255 352.0 ＋ ー ー
256 126.0 ー ー ー
257 364.0 ー ー ー/＋
258 68.0 ー ー ー
259 55.0 ー ー ー
260 115.5 ー ー ー
262 69.5 ー ー ー
263 179.0 ー ー ー
264 96.5 ー ー ー
266 143.5 ー ー ー
267 94.5 ー ー ー
268 123.5 ー ー ＋
269 194.5 ー ー ＋
270 94.5 ー/＋ ー ー
271 70.0 ＋ ー ー
272 123.5 ー ー ー/＋
275 237.5 ー ー ー
276 79.0 ー ー ー
277 80.5 ー/＋ ー ー/＋
278 82.0 ー ＋ ー
279 201.5 ＋ ＋ ー
280 381.0 ー ー ー
281 161.0 ー ー ー
282 360.0 ー ー/＋ ー
284 306.0 ー ー ー
285 215.5 ー ー ー
290 79.5 ー ー ー
291 339.5 ー ー ー
292 236.0 ー ー ー
293 109.5 ー ー ー
294 273.0 ー ー/＋ ー
295 168.0 ー ー/＋ ー/＋
296 289.0 ー ー ー
297 302.5 ー ー ー
298 213.5 ー ー ー
299 119.5 ー ー ＋
300 191.5 ー ー ー
301 165.0 ー ＋ ＋
302 103.0 ー ー/＋ ー
Nested-PCR
Sample No. DNA conc. (ng/µl)
Table 2. Results of B1-nested PCR using DNA extracted from 107 raccoon 
brains  
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Table 3. Summary of primers for real time PCR 
 
 
 
Target Primer Name Nucleotide sequence Expected amplicon sizea Reference 
cox1 cox1rt-F 5’-ATGCAGGTATGGATATTGCACT-3’ 132bp this study 
  cox1rt-R 5’-GTATCTCCGAACATATCTTTACT-3’   
18S rRNA 18Srt-F 5’-ACCGTGGTAATTCTATGGCTAA-3’ 130bp this study 
  18Srt-R 5’-ACGCGATCCGTTCGGTTACT-3’     
P30 P30rt-F1 5’-TTTGTGGTCGGTTGCATCAAGGGA-3’ 107bp this study 
  P30rt-R1 5’-TAGGAGCACCTTGCGACATTATTGA-3’   
B1 B1rt-F 5’-TCTCTCAAGGAGGACTGGCA-3’ 131bp Costa et al., 2012 
  B1rt-R 5’-GTTTCACCCGGACCGTTTAG-3’     
AF146527 AF146527rt-F 5’-GTTGGGAAGCGACGAGAGTC-3’ 134bp Costa et al., 2012 
  AF146527rt-R 5’-ATTCTCTCCGCCATCACCAC-3’     
aAmplicon sizes were calculated based on nucleotide sequences of T.gondii ME49 strain.  
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Table 4. Mean ratios for relative quantification of the cox1gene, B1 gene, 
AF146527 element, 18S rRNA gene compared to the single-copy P30 gene in the 
Fukaya and RH strains. 
 
 
 
Starin Evaluated/Reference Mean (SD) ratio 
Fukaya cox1/P30 175.9 (0.9) 
 B1/P30 16.6 (0.7) 
 AF146527/P30 353.6 (20.4) 
  18S rRNA/P30 61.5 (2.4) 
RH cox1/P30 81.4 (0.6) 
 B1/P30 16.4 (0.7) 
 AF146527/P30 197.7 (4.6) 
  18S rRNA/P30 38.0 (0.7) 
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Table 5. Summary of primers for PCR in chapter 3 
  
 
 
      
Target Primer name Nucleotide sequence 
Expected 
amplicon sizea 
Anealing 
tempreture 
Extension 
time Reference 
cox1 cox1- F 
5’-
GTAGTTATGGGTAATGCAGGTATGGA-
3' 
295 bp 52oC 30s this study 
 cox1- R 5’-AATCAGGGTAATCTGGGATCCTTCT-3’       
B1 B1- F 5’-GCACCTTTCGGACCTCAACAACCG-3’ 288 bp 55
oC 30s Okay et al.,  2009 
 B1- R 5’-TTCTCGCCTCATTTCTGGGTCTAC-3’      
AF146527 AF- F 
5’-
CGCTGCAGGGAGGAAGACGAAAGTTG-
3’ 
527 bp 55oC 60s Homan et al., 1999 
 AF- R 5’-CGCTGCAGACACAGTGCATCTGGATT-3’       
18S rRNA 18S - F 5’-GGCATTCCTCGTTGAAGATT-3’ 88 bp 55oC 100s Dupon et al., 1995 
 18S - R 5’-CCTTGGCCGATAGGTCTAGG-3’         
aAmplicon sizes were calculated based on nucleotide sequences of T.gondii 
ME49 strain. 
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Table 6. Comparative results of PCR targeting three genes and an AF146527 repeat element for peripheral blood of 24 
patients and 6 asymptomatic volunteers through two tests. 
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Figure legends 
Figure 1. Feline as Toxoplasma of the definitive host can shed oocysts of Toxoplasma in faeces. The intermediate hosts in 
nature become infected after ingesting soil, water and plants contaminated with Toxoplasma oocysts. The human can get 
infection via the following three main ways: first, orally ingest water and food contaminated with oocysts shed in the faeces 
from the definitive host; second, the parasite is transmitted by consumption of undercooked or raw meat with tissue cysts; 
third, transmission tachyzoites from mother to the fetus. 
 
Figure 2. Japan is an island country located on the eastern coast of the Asian continent. The 107 wild raccoon samples used 
in this research from Hokkaido, north of Japan. 
 
Figure 3. 107 DNA samples of raccoon brain tissues were detected. In the 1 test, 13% of samples (14/107) were detected with 
Toxoplasma DNA. In the 2 test, 12% samples (13/107) showed contain Toxoplasma DNA; In the 3 test, 20% (22/107) samples 
of Toxoplasma DNA was detected. 
 
Figure 4. Detection sensitivities of PCRs targeting the coxl gene, B1 gene, AF146527 repeat element, and 18S rRNA. Five-
fold serial dilution (5–57) of the DNA solution was performed. The amplicon sizes of each fragment are shown in Table 6. M: 
100-bp DNA ladder. 
 
Figure 5A. Detection sensitivities of PCRs using 24 clinical samples and 6 asymptomatic volunteers, targeting the cox1 gene, 
B1 gene, AF143527 repeat element, and 18S rRNA gene (First trial). 
5-Fold and 52-fold dilutions of the DNA solution were performed. The amplicon sizes of each fragment are shown in Table 6. 
M: 100-bp DNA ladder. 
 
Figure 5B. Detection sensitivities of PCRs using 24 clinical samples and 6 asymptomatic volunteers, targeting the cox1 
gene, B1 gene, AF143527 repeat element, and 18S rRNA gene (Second trial). 
5-Fold and 52-fold dilutions of the DNA solution were performed. The amplicon sizes of each fragment are shown in Table 6. 
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M: 100-bp DNA ladder. 
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Figure 1.  
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Figure 2. 
 
 
 
 
 
62 
 
 
Figure 3. 
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Figure 4. 
 
 
 
 
 
  
64 
 
Figure 5A. 
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Figure 5A. (continued) 
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Figure 5B.  
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Figure 5B. (continued) 
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